ANXA9 and ovarian serous tumor: Figure 7 shows that upregulation of ANXA8 (Fig. 7f), ANXA9 (Fig. 7g), and ANXA11 (Fig. 7i) mRNAs was significantly correlated with poor PFS in patients with ovarian serous tumors, whereas ANXA7 (Fig. 7e) mRNA downregulation was correlated with poor PFS.